Effects of chronic treatment with methadone and naltrexone on sleep in addicts

European Archives of Psychiatry and Clinical Neuroscience

Volumn 246, Issue 6, 1996, Pages 305-309

  Staedt, J ^a   Wassmuth, F ^a   Stoppe, G ^a   Hajak, G ^a   Rodenbeck, A ^a   Poser, W ^a   Ruther E ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Methadone; Naltrexone; Opioid dopamine interaction; Sleep disturbance

Indexed keywords

METHADONE; NALTREXONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABUSE PATTERN; DRUG DEPENDENCE; ELECTROENCEPHALOGRAM; FEMALE; HEROIN DEPENDENCE; HUMAN; LONG TERM CARE; MALE; PRIORITY JOURNAL; RELAPSE; SLEEP; SLEEP DISORDER; SLEEP TIME;

ADULT; ANALGESICS, OPIOID; FEMALE; HEROIN; HUMANS; MALE; METHADONE; NALTREXONE; NARCOTIC ANTAGONISTS; SLEEP; SUBSTANCE-RELATED DISORDERS;

EID: 0029848993     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02189023     Document Type: Article

References (34)

1. Agnew HW, Webb WB, Williams RL (1967) Comparison of stage four and I-REM sleep deprivation. Percept Mot Skills 24: 851- 858
2. Blois R, Feinberg I, Gaillard J-M, Kupfer DJ, Webb WB (1983) Sleep in normal and pathological ageing. Experientia 39: 551- 558
3. Capone T, Brahen L, Condren R, Kordal N, Melchionda R, Peterson M (1986) Retention and outcome in a narcotic antagonist treatment program. Clin Psychol 42: 825-833
4. Carskadon MA, Dement WC, Mitler MM, Guilleminault G, Zarcone VP, Spiegel R (1976) Self-reports versus sleep laboratory findings in 122 drug-free subjects with complaints of chronic insomnia. Am J Psychiatry 133: 1382-1388
5. Chesselet MF, Cheramy A, Reisine TD, Lubetzki M, Desban M, Glowinski J (1983) Local and distal effects induced by unilateral striatal application of opiates in the absence or in the presence of naloxone on the release of dopamine in both caudate nuclei and substantiae nigrae of the cat. Brain Res 258: 229- 242
6. Chiara G di, Imperato A (1988) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244: 1067-1080
7. Coursey RD, Buchsbaum M, Frankel B (1975) Personality measures and evoked responses in chronic insomnia. J Abnorm Psychol 84: 239-249
8. Ford DE, Kamerow DB (1989) Epidemiologic study of sleep disturbance and psychiatric disorders. J Am Med Assoc 262: 1479-1484
9. Fratta W, Collu M, Martellotta MC, Pichiri M, Munloni F, Gessa GL (1987) Stress-induced insomnia: opioid-dopamine interactions. Eur J Pharmacol 142: 437-440
10. Hemmeter U, Kocher R, Ladewig D, Holsboer-Trachsler E (1993) EMG-Störungen im REM-Schlaf bei Suchtpatienten. Therapeutische Umschau 50: 169-177
11. Hening W, Walters A, Kavey N, Gidro-Frank S, Cote L, Fahn S (1986) Dyskinesias while awake and periodic movements in sleep in restless Legs syndrome: treatment with opioids. Neurology 36: 1363-1366
12. Isbell H, Wikler A, Eisenman AJ, Daingerfield M, Frank K (1948) Liability of addiction to 6-dimethylamino-4.4-diphenyl-3-heptanone methadone, "amidone" or "10820") in man. Arch Intern Med 82: 362-392
13. Kales A, Caldwell AB, Preston TA, Healy S, Kales JD (1976) Personality patterns in insomnia. Arch Gen Psychiatry 33: 1128- 1134
14. Kay DC (1975a) Human sleep during chronic morphine intoxication. Psychopharmacologia 44: 117-124
15. Kay DC (1975b) Human sleep and EEG through a cycle of methadone dependence. Electroenceph Clin Neurophysiol 38: 35-43
16. Magruder-Habib K, Hubbard RL, Ginzburg HM (1992) Effects of drug misuse treatment on symptoms of depression and suicide. Int J Addictions 27: 1035-1065
17. Martin WR, Jasinski DR, Heartzen CA, Kay DC, Jones BE, Mansky PA, Carpenter RW (1973) Methadone: a reevaluation. Arch Gen Psychiatry 28: 286-295
18. McGinty DJ (1982) Sleep mechanisms: Biology and control of REM sleep. Int Rev Neurobiol 23: 391-436
19. Merica H, Gaillard J-M (1985) Statistical description and evaluation of the interrelationships of standard sleep variables for normal subjects. Sleep 8: 261-273
20. Moldofsky H, Scarisbrick P, England R, Smythe H (1975) Musculosceletal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med 37: 341-351
21. Monroe LJ (1967) Psychological and physiological differences between good and poor sleepers. J Abnorm Psychol 72: 255-264
22. Olesen OV, Linnet K, Rosenberg R (1995) Results of urinary control analyses of narcotic addicts on methadone therapy. An evaluation in the county of Rhus in 1993. Ugeskr Laeger 157: 719-723
23. Poser W, Poser S, Eva-Condemarin P (1992) Mortality in patients with dependence on prescription drugs. Drug Alcohol Depend 30: 49-57
24. Püschel K (1993) Drug-related death - an update. Forensic Sci Int 62: 121-128
25. Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Brain Information Service/Brain Research Institute, UCLA, Los Angeles
26. Roubicek J, Zaks A, Freedman AM (1969) EEG changes produced by heroin and methadone. Electroenceph Clin Neurophysiol 27: 667-668
27. Rounsaville BJ, Kosten TR, Kleber HD (1986) Long-term changes in current psychiatric diagnoses of treated opiate addicts. Compr Psychiatry 27: 80-498
28. Segawa M, Nomura Y (1991) Rapid eye movements during stage REM are modulated by nigrostriatal dopamine neurons? In: Bernadi G, Carpenter MB, DiChiara G, Morelli M, Stanzione P (eds) The basal ganglia III. Plenum Press, New York, pp 663- 671
29. Shufman EN, Porat S, Witztum E, Gandacu D, Bar-Hamburger R, Ginath Y (1994) The efficacy of naltrexone in preventing reabuse of heroin after detoxification. Biol Psychiatry 35: 935- 945
30. Staedt J, Windt H, Hajak G, Stoppe G, Rudolph G, Ensink FBM, Hildebrandt J, Rüther E (1993) Cluster arousal analysis in chronic pain disturbed sleep. J Sleep Res 2: 34-137
31. Staedt J, Stoppe G, Kögler A, Riemann H, Hajak G, Munz DL, Emrich D, Rüther E (1995a) Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2- receptor alteration. Eur Arch Psychiatry Clin Neurosci 245: 8-10
32. Staedt J, Stoppe G, Kögler A, Riemann H, Hajak G, Munz DL, Emrich D, Rüther E (1995b) Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS). J Neural Transm [Gen Sect] 99: 187- 193
33. Vries TJ de, Tjon Tien Ril GHK, Van der Laan JW, Mulder AH, Schoffelmeer ANM (1993) Chronic exposure to morphine and naltrexone induces changes in catecholaminergic neurotransmission in rat brain without altering m-opioid receptor sensitivity. Life Sci 52: 1685-1693
34. Zerssen D von, Koeller D-M (1976) Klinische Selbstbeurteilungs- Skalen (KSb-S) aus dem Münchner Psychiatrischen Informations-System (Psychis München). Beltz Test Gesellschaft, Weinheim